Dados B3 › KRSA3
KRSA3 (Kora Saúde Participações): has debt gone up?
KRSA3 (Kora Saúde Participações): at the end of 2025, net debt was R$ 3.1 billion, 7.94 times the year's EBITDA; in 2024, R$ 2.7 billion.
| Year | Net debt | Net debt / EBITDA | Caveat |
|---|---|---|---|
| 2025 | R$ 3.1 billion | 7.94 | — |
| 2024 | R$ 2.7 billion | 6.26 | — |
| 2023 | R$ 2.4 billion | 5.22 | — |
| 2022 | R$ 1.6 billion | 4.15 | — |
| 2021 | R$ 1.3 billion | 6.26 | — |
| 2020 | R$ 502.9 million | 4.70 | — |
Net debt = short- and long-term borrowings minus cash and financial investments, at year end. Negative = net cash. EBITDA = operating result plus depreciation and amortization. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/KRSA3/indicadores - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: KRSA3.
Dividends · Profit · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:11 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:11 UTC. If this does not match /saude, you are reading a cached copy.